Long-term complete remission with belinostat in a patient with chemotherapy refractory peripheral T-cell lymphoma.
about
Phenethyl isothiocyanate and paclitaxel synergistically enhanced apoptosis and alpha-tubulin hyperacetylation in breast cancer cellsPotentiating antilymphoma efficacy of chemotherapy using a liposome for integration of CD20 targeting, ultra-violet irradiation polymerizing, and controlled drug delivery.Profile of belinostat for the treatment of relapsed or refractory peripheral T-cell lymphoma.c-FLIP is involved in tumor progression of peripheral T-cell lymphoma and targeted by histone deacetylase inhibitors.New developments in the treatment of peripheral T-cell lymphoma - role of Belinostat.HR23b expression is a potential predictive biomarker for HDAC inhibitor treatment in mesenchymal tumours and is associated with response to vorinostat.Belinostat for the treatment of relapsed or refractory peripheral T-cell lymphoma.Controlled and Targeted Drug Delivery by a UV-responsive Liposome for Overcoming Chemo-resistance in Non-Hodgkin Lymphoma.Autologous stem cell transplantation as frontline strategy for peripheral T-cell lymphoma: A single-centre experienceCEPP regimen (cyclophosphamide, etoposide, procarbazine and prednisone) as initial treatment for Hodgkin lymphoma patients presenting with severe abnormal liver function.Epigenetic priming of non-small cell lung cancer cell lines to the antiproliferative and differentiating effects of all-trans retinoic acid.
P2860
Q28396209-99F782EA-7DCA-4CA7-8796-BDC5BB485C73Q34116979-20D9DEA7-A165-4D7B-86D4-634DE56D59B9Q34434810-5770A7F6-B5C3-42CC-BA06-2543A9EFB7C7Q34667550-7566B7D5-F246-4E70-A1BB-A6EEC21D2C6EQ35703714-2808B340-28DC-47B8-AA50-F0A03C81734AQ37002069-712F2D0D-AEE8-413A-A164-29DDA1BA06A8Q38752460-0D87C8DC-D27A-499B-B339-9253EB89ACBDQ38903528-D96B6F1A-BDAA-4BE8-978F-ED33E9A2C14FQ38949798-698074E1-252F-443B-921B-3081FF8E79AEQ42717244-0A1D4AA6-3F8E-4BC1-8AF2-8106BCE023A6Q52941090-3713871C-244D-40F1-A39F-2579271278EC
P2860
Long-term complete remission with belinostat in a patient with chemotherapy refractory peripheral T-cell lymphoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Long-term complete remission w ...... ry peripheral T-cell lymphoma.
@en
Long-term complete remission w ...... ry peripheral T-cell lymphoma.
@nl
type
label
Long-term complete remission w ...... ry peripheral T-cell lymphoma.
@en
Long-term complete remission w ...... ry peripheral T-cell lymphoma.
@nl
prefLabel
Long-term complete remission w ...... ry peripheral T-cell lymphoma.
@en
Long-term complete remission w ...... ry peripheral T-cell lymphoma.
@nl
P2860
P921
P356
P1476
Long-term complete remission w ...... ry peripheral T-cell lymphoma.
@en
P2093
Peter Reimer
Shanta Chawla
P2860
P2888
P356
10.1186/1756-8722-6-69
P577
2013-09-10T00:00:00Z
P5875
P6179
1014852255